6-K

AURINIA PHARMACEUTICALS INC. 6-K

Company: Aurinia Pharmaceuticals Inc.
Filed: June 16, 2017
Period of Report: June 16, 2017
Accession Number: 0001157523-17-001796

View Document ↗ View on SEC.gov ↗